MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

Clinical Cancer Research

Volumn 18, Issue 10, 2012, Pages 2828-2837

  Burnichon, Nelly ^a,b,c   Cascoń, Alberto ^g,h   Schiavi, Francesca ⁱ   Morales, NicolePaes ^k   Comino Méndez, Iñaki ^g   Abermil, Nasséra ^a,b,c   Inglada Pérez, Lucía ^g,h   De Cubas, Aguirre A ^g   Amar, Laurence ^a,b,c   Barontini, Marta ^m   De Quiroś, Sandra Bernaldo ⁿ   Bertherat, Jérôome ^b,d   Bignon, Yves Jean ^o   Blok, Marinus J ^p   Bobisse, Sara ⁱ   Borrego, Salud ^h,q   Castellano, Maurizio ^r   Chanson, Philippe ^e   Chiara, María Dolores ⁿ   Corssmit, Eleonora P M ^s   Giacchè, Mara ^r   De Krijger, Ronald R ^t   Ercolino, Tonino ^u   Girerd, Xavier ^f   Gómez Garćia, Encarna B ^p   Gómez Graña, Álvaro ^g   Guilhem, Isabelle ^x   Hes, Frederik J ^s   Honrado, Emiliano ^y   Korpershoek, Esther ^t   Lenders, Jacques W M ^z   Letón, Rocío ^g   Mensenkamp, Arjen R ^z   Merlo, Anna ⁿ   Mori, Luigi ^r   Murat, Arnaud ^aa   Pierre, Peggy ^ab   Plouin, Pierre François ^a,b,c   Prodanov, Tamara ^ac   Quesada Charneco, Miguel ^ad   Qin, Nan ^ae   Rapizzi, Elena ^v   Raymond, Victoria ^af   Reisch, Nicole ^ag   Roncador, Giovanna ^g   Ruiz Ferrer, Macarena ^h,q   Schillo, Frank ^ah   Stegmann, Alexander P A ^p   Suarez, Carlos ⁿ   Taschin, Elisa ⁱ   Timmers, Henri J L M ^z   Tops, Carli M J ^s   Urioste, Miguel ^g,h   Beuschlein, Felix ^ag   Pacak, Karel ^ac   Mannelli, Massimo ^v,w   Dahia, Patricia L M ^k,l   Opocher, Giuseppe ^j   Eisenhofer, Graeme ^ae   Gimenez Roqueplo, Anne Paule ^a,b,c   Robledo, Mercedes ^g,h   more..

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d INSTITUT COCHIN   (France)

^e BICÊTRE HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Centro Nacional de Investigaciones Oncológicas   (Spain)

^h CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

ⁱ VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k Mays Cancer Center at UT Health San Antonio   (United States)

^l University of Texas Health Science Center at San Antonio   (United States)

^m HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

ⁿ DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^o CENTRE JEAN PERRIN   (France)

^p MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^q HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^r UNIVERSITY OF BRESCIA   (Italy)

^s LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^t ERASMUS MEDICAL CENTER   (Netherlands)

^u CAREGGI UNIVERSITY HOSPITAL   (Italy)

^v UNIVERSITY OF FLORENCE   (Italy)

^w ISTITUTO TOSCANO TUMORI   (Italy)

^x RENNES UNIVERSITY HOSPITAL   (France)

^y HOSPITAL DE LEÓN   (Spain)

^z RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^aa CHU de Nantes   (France)

^ab CHU BRETONNEAU   (France)

^ac EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^ad HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^ae UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^af UNIVERSITY OF MICHIGAN   (United States)

^ag LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^ah UNIVERSITY HOSPITAL OF BESANÇON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METADRENALIN; NORMETADRENALIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION RATE; MUTATIONAL ANALYSIS; MYC ASSOCIATED FACTOR X GENE; NUCLEOTIDE SEQUENCE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; URINE VOLUME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; YOUNG ADULT;

EID: 84861140704     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0160     Document Type: Article

References (20)

1. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20. (Pubitemid 23231974) (Pubitemid 23231974)
2. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-60. (Pubitemid 23179393) (Pubitemid 23179393)
3. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991;353:864-6.
4. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-51. (Pubitemid 30084326) (Pubitemid 30084326)
5. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54. (Pubitemid 32614017) (Pubitemid 32614017)
6. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-70.
7. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-66. (Pubitemid 34755714) (Pubitemid 34755714)
8. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009;325:1139-42.
9. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010;19:3011-20.
10. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010;42:229-33.
11. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacche M, Mori L, et al. Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 2009;94:1541-7.
12. Cascon A, Pita G, Burnichon N, Landa I, Lopez-Jimenez E, Montero-Conde C, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 2009;94:1701-5.
13. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro-Garcia LJ, Leton R, et al. Exome sequencing identifiesMAXmutations as a cause of hereditary pheochromocytoma. Nat Genet 2011;43:663-7.
14. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 2005;8:155-67. (Pubitemid 41132744) (Pubitemid 41132744)
15. Maher ER, Eng C. The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 2002;11:2347-54. (Pubitemid 35174697)
16. Burnichon N, Vescovo L, Amar L, Libe R, de Reynies A, Venisse A, et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet 2011;20:3974-85.
17. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
18. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008;8:976-90.
19. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8. (Pubitemid 46211527) (Pubitemid 46211527)
20. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009;94:2817-27.